ClinicalTrials.gg
Sign In

Gallbladder Diseases clinical trials

The registry lists 92 studies for Gallbladder Diseases across more than 10 countries. 19 are recruiting or about to start. 54 of them are mainly about Gallbladder Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-15. Counting its 5 narrower conditions too, such as Gallbladder Neoplasms: 874 studies, 174 open.

Get an email when these change. Save the Gallbladder Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
53
Status unknown
15
Recruiting
14
Not yet recruiting
5
Withdrawn
3
Terminated
2

Phase

Phase 2
4
Phase 4
2
Phase 3
2
Phase 1
1

Where

United States
21
Italy
7
Korea, Republic of
7
China
7
Turkey
5
Egypt
5

Who runs them

Ajou University School of Medicine (6) · Merck Sharp & Dohme LLC (2) · Assiut University (2) · Intuitive Surgical (2) · Tecnologico de Monterrey (2) · University of Calgary (2) · Second Affiliated Hospital, School of Medicine, Zhejiang University (2) · Sisli Hamidiye Etfal Training and Research Hospital (2)

What is being tested here

Drugs under test in Gallbladder Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Duloxetine111
Sugammadex003
Regorafenib001
Palonosetron001
Lidoderm001
Lidocaine001
Ibuprofen001

Coming up

1phase 3 study under way
5studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 5, phase 3 first

Who these studies take

Of the 14 Gallbladder Diseases studies recruiting now, 9 (64%) set no upper age limit and 2 (14%) stop at 75 or younger. 2 (14%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (7%) take healthy volunteers.

Recruiting studies that take each age, of 14
AgeWomenMen
102 (14%)2 (14%)
1813 (93%)13 (93%)
3013 (93%)13 (93%)
4013 (93%)13 (93%)
5013 (93%)13 (93%)
6513 (93%)13 (93%)
7512 (86%)12 (86%)
8511 (79%)11 (79%)

Across all 92 studies, recruiting or not: 21% stop at 75 or younger and 14% at 65; 16% take children; 4% are for women only and 3% for men only; 17% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Gallbladder Diseases studies take

Of 34 interventional studies with no phase under Gallbladder Diseases, half reached primary completion within 14 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase14 mo8–26 · 34 studies—13 mo7–26 · 32 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 92. Browse all 92 → or search them.